Literature DB >> 26206875

Mefloquine as a potential drug against multidrug-resistant tuberculosis.

David Krieger1, Silvan Vesenbeckh2, Nicolas Schönfeld2, Gudrun Bettermann3, Torsten Thomas Bauer4, Holger Rüssmann3, Harald Mauch3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26206875     DOI： 10.1183/13993003.00321-2015

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  7 in total

1.  Susceptibilities of MDR Mycobacterium tuberculosis isolates to unconventional drugs compared with their reported pharmacokinetic/pharmacodynamic parameters.

Authors:  Joseph S Cavanaugh; Ruwen Jou; Mei-Hua Wu; Tracy Dalton; Ekaterina Kurbatova; Julia Ershova; J Peter Cegielski
Journal:  J Antimicrob Chemother       Date:  2017-06-01       Impact factor: 5.790

2.  Second generation of primaquine ureas and bis-ureas as potential antimycobacterial agents.

Authors:  Kristina Pavić; Zrinka Rajić; Hana Michnová; Josef Jampílek; Ivana Perković; Branka Zorc
Journal:  Mol Divers       Date:  2018-12-06       Impact factor: 2.943

3.  Population Pharmacokinetics of Mefloquine Intermittent Preventive Treatment for Malaria in Pregnancy in Gabon.

Authors:  Michael Ramharter; Matthias Schwab; Clara Menendez; Reinhold Kerb; Thorsten Lehr; Ghyslain Mombo-Ngoma; Rella Zoleko Manego; Daisy Akerey-Diop; Arti Basra; Jean-Rodolphe Mackanga; Heike Würbel; Jan-Georg Wojtyniak; Raquel Gonzalez; Ute Hofmann; Mirjam Geditz; Pierre-Blaise Matsiegui; Peter G Kremsner
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

Review 4.  Carbapenems to Treat Multidrug and Extensively Drug-Resistant Tuberculosis: A Systematic Review.

Authors:  Giovanni Sotgiu; Lia D'Ambrosio; Rosella Centis; Simon Tiberi; Susanna Esposito; Simone Dore; Antonio Spanevello; Giovanni Battista Migliori
Journal:  Int J Mol Sci       Date:  2016-03-12       Impact factor: 5.923

Review 5.  Primaquine derivatives: Modifications of the terminal amino group.

Authors:  Branka Zorc; Ivana Perković; Kristina Pavić; Zrinka Rajić; Maja Beus
Journal:  Eur J Med Chem       Date:  2019-08-23       Impact factor: 6.514

Review 6.  Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection.

Authors:  Weibao Song; Hongjuan Zhang; Yu Zhang; Rui Li; Yanxing Han; Yuan Lin; Jiandong Jiang
Journal:  Front Med       Date:  2020-12-28       Impact factor: 4.592

7.  Unlike Chloroquine, Mefloquine Inhibits SARS-CoV-2 Infection in Physiologically Relevant Cells.

Authors:  Carolina Q Sacramento; Natalia Fintelman-Rodrigues; Suelen S G Dias; Jairo R Temerozo; Aline de Paula D Da Silva; Carine S da Silva; Camilla Blanco; André C Ferreira; Mayara Mattos; Vinicius C Soares; Filipe Pereira-Dutra; Milene Dias Miranda; Debora F Barreto-Vieira; Marcos Alexandre N da Silva; Suzana S Santos; Mateo Torres; Otávio Augusto Chaves; Rajith K R Rajoli; Alberto Paccanaro; Andrew Owen; Dumith Chequer Bou-Habib; Patrícia T Bozza; Thiago Moreno L Souza
Journal:  Viruses       Date:  2022-02-11       Impact factor: 5.048
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.